Trails Edge Capital Partners, LP / AM6
Trails Edge Capital Partners, LP’s Amicus Therapeutic Position
Does Trails Edge Capital Partners, LP own Amicus Therapeutic (AM6)? Not currently — the last reported position was 1.04M shares worth $15M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$15M
Q4 2025
Shares
1.04M
% of Portfolio
+3.67%
Quarters Held
1
position exited
Position History AM6
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 1.04M | $15M | +3.67% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of AM6.